Table 1.
Demographic characteristic of the patient’s study.
|
Group
|
p Value | ||||
|---|---|---|---|---|---|
| L-carnitine (n = 25) | Lipofundin (n = 25) | L-carnitine + Lipofundin (n = 25) | Control (n = 25) | ||
| Age, Mean, SD | 62.48 (8.76) | 63.24 (9.35) | 60.56 (8.55) | 63.44 (6.54) | 0.61 |
| Sex, F/M | 14/11 | 14/11 | 7/18 | 8/17 | 0.08 |
| BMI, kg/m², Mean, SD | 24.81 (4.03) | 23.76 (2.83) | 26.48 (3.63) | 25.20 (4.37) | 0.09 |
| Undergraduate education, n (%) | 14 (56) | 17 (68) | 12 (48) | 14 (56) | 0.56 |
| Married, n (%) | 21 (84) | 23 (92) | 23 (92) | 23 (92) | 0.72 |
| IHD, n (%) | 5 (20) | 6 (24) | 2 (8) | 2 (8) | 0.26 |
| DM, n (%) | 1 (4) | 0 (0) | 3 (12) | 1 (4) | 0.26 |
| HTN, n (%) | 10 (40) | 13 (52) | 5 (20) | 4 (16) | 0.02 |
| DLP, n (%) | 10 (40) | 10 (41.7) | 6 (24) | 7 (28) | 0.47 |
| NIHSS, Mean (SD) | 8.48 (3.19) | 8.88 (2.93) | 7.44 (2.86) | 8.24 (2.8) | 0.38 |
Body Mass Index (BMI), Ischemic Heart Disease (IHD), Diabetes Melitus (DM), Hypertension (HTN), Dislipidemia(DLP), National Institutes of
Health Stroke Scale (NIHSS), Standard deviation (SD)